Can a 2-Week app ease anxiety and depression? norway launches large trial
NCT ID NCT07627204
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test two smartphone apps, Tankevirus and Grubl, designed to help people with mild to moderate anxiety and depression. About 1000 Norwegian adults will use one of the apps or a placebo app for two weeks. Researchers will measure changes in symptoms and quality of life over six months to see if the apps are helpful and cost-effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- smartphone app (Tankevirus or Grubl)
- What this could lead to
- If successful, these apps could provide a low-cost, accessible way to reduce anxiety and depression symptoms without needing a therapist.
- What could go wrong
- This is a protocol for a trial that hasn't started yet. The apps are brief (2 weeks) and effects may be small or not last long. Results may not apply outside Norway.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Akershus University Hospital
Lørenskog, Akershus, 1978, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a VR headset calm nerves before surgery?
- Nature as therapy? a new trial tests outdoor outings for anxious kids